R Mazzilli
Overview
Explore the profile of R Mazzilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Natalicchio A, Marrano N, Montagnani M, Gallo M, Faggiano A, Zatelli M, et al.
J Endocrinol Invest
. 2024 Jun;
47(12):2915-2928.
PMID: 38935200
Background: Increasing evidence suggests that diabetes increases the risk of developing different types of cancer. Hyperinsulinemia, hyperglycemia and chronic inflammation, characteristic of diabetes, could represent possible mechanisms involved in cancer...
2.
Salvia A, Marcozzi B, Manai C, Mazzilli R, Landi L, Pallocca M, et al.
J Endocrinol Invest
. 2024 Mar;
47(10):2575-2586.
PMID: 38520655
Background: Lung NET, classified in typical carcinoids (TC) and atypical carcinoids (AC), are highly heterogeneous in their biology and prognosis. The histological subtype and TNM stage are well-established prognostic factors...
3.
Taggi M, Capponi C, Bertani N, Saturno G, Innocenti F, Dovere L, et al.
J Endocrinol Invest
. 2024 Jan;
47(7):1719-1732.
PMID: 38190029
Purpose: To evaluate the impact of high thyroid stimulating hormone (TSH) levels on human granulosa-luteal (hGL) cells. Methods: hGL cells were isolated from follicular aspirates derived from patients undergoing IVF...
4.
Silvestris N, Franchina T, Gallo M, Argentiero A, Avogaro A, Cirino G, et al.
ESMO Open
. 2023 Dec;
8(6):102062.
PMID: 38070434
Cancer management has significantly evolved in recent years, focusing on a multidisciplinary team approach to provide the best possible patient care and address the various comorbidities, toxicities, and complications that...
5.
Zamponi V, Haxhi J, Pugliese G, Faggiano A, Mazzilli R
J Endocrinol Invest
. 2023 Nov;
47(6):1315-1321.
PMID: 37987916
Purpose: The aim of this review is to evaluate the effects of new technology used in the management of diabetes mellitus (DM), including the use of continuous glucose monitoring (CGM)...
6.
Ruggeri R, Altieri B, Razzore P, Retta F, Sperti E, Scotto G, et al.
J Endocrinol Invest
. 2023 Oct;
47(4):959-971.
PMID: 37837555
Background: The incidence of neuroendocrine neoplasm (NEN) and related carcinoid syndrome (CaS) has increased markedly in recent decades, and women appear to be more at risk than men. As per...
7.
Natalicchio A, Montagnani M, Gallo M, Marrano N, Faggiano A, Zatelli M, et al.
ESMO Open
. 2023 Jun;
8(3):101573.
PMID: 37263082
Increasing evidence suggests that patients with diabetes, particularly type 2 diabetes (T2D), are characterized by an increased risk of developing different types of cancer, so cancer could be proposed as...
8.
Mazzilli R, Zamponi V, Mangini F, Olana S, Defeudis G, Faggiano A, et al.
J Endocrinol Invest
. 2023 Jan;
46(7):1465-1473.
PMID: 36656432
Purpose: To evaluate the association among andrological diseases at the first outpatient visit and the medications taken by patients for other comorbidities, as well as the differential impact between specific...
9.
Mazzilli R, Rucci C, Vaiarelli A, Cimadomo D, Ubaldi F, Foresta C, et al.
J Endocrinol Invest
. 2023 Jan;
46(6):1079-1085.
PMID: 36633791
Background: Infertility, which is defined as the inability to conceive after at least 12 months of regular unprotected sexual intercourses, affects about 15-20% of couples worldwide and a male factor...
10.
Mazzilli R, Medenica S, Di Tommaso A, Fabozzi G, Zamponi V, Cimadomo D, et al.
J Endocrinol Invest
. 2022 Aug;
46(1):15-26.
PMID: 35945393
Purpose: We herein aimed to review the new insights into the impact of impaired thyroid function on male and female fertility, spacing from spontaneous pregnancy to ART, with the objective...